157 related articles for article (PubMed ID: 15795267)
1. Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo.
Ito H; Sommer MH; Zerboni L; Baiker A; Sato B; Liang R; Hay J; Ruyechan W; Arvin AM
J Virol; 2005 Apr; 79(8):4819-27. PubMed ID: 15795267
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus.
Sommer MH; Zagha E; Serrano OK; Ku CC; Zerboni L; Baiker A; Santos R; Spengler M; Lynch J; Grose C; Ruyechan W; Hay J; Arvin AM
J Virol; 2001 Sep; 75(17):8224-39. PubMed ID: 11483768
[TBL] [Abstract][Full Text] [Related]
3. The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo.
Baiker A; Bagowski C; Ito H; Sommer M; Zerboni L; Fabel K; Hay J; Ruyechan W; Arvin AM
J Virol; 2004 Feb; 78(3):1181-94. PubMed ID: 14722273
[TBL] [Abstract][Full Text] [Related]
4. Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo.
Che X; Zerboni L; Sommer MH; Arvin AM
J Virol; 2006 Apr; 80(7):3238-48. PubMed ID: 16537591
[TBL] [Abstract][Full Text] [Related]
5. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse.
Moffat JF; Zerboni L; Sommer MH; Heineman TC; Cohen JI; Kaneshima H; Arvin AM
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11969-74. PubMed ID: 9751774
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo.
Sato B; Ito H; Hinchliffe S; Sommer MH; Zerboni L; Arvin AM
J Virol; 2003 May; 77(10):5607-20. PubMed ID: 12719553
[TBL] [Abstract][Full Text] [Related]
7. Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo.
Ito H; Sommer MH; Zerboni L; He H; Boucaud D; Hay J; Ruyechan W; Arvin AM
J Virol; 2003 Jan; 77(1):489-98. PubMed ID: 12477854
[TBL] [Abstract][Full Text] [Related]
8. Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo.
Moffat J; Mo C; Cheng JJ; Sommer M; Zerboni L; Stamatis S; Arvin AM
J Virol; 2004 Nov; 78(22):12406-15. PubMed ID: 15507627
[TBL] [Abstract][Full Text] [Related]
9. Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of varicella-zoster virus.
Jones JO; Arvin AM
Antiviral Res; 2005 Nov; 68(2):56-65. PubMed ID: 16118026
[TBL] [Abstract][Full Text] [Related]
10. Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection.
Che X; Reichelt M; Sommer MH; Rajamani J; Zerboni L; Arvin AM
J Virol; 2008 Jun; 82(12):5825-34. PubMed ID: 18400847
[TBL] [Abstract][Full Text] [Related]
11. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
[TBL] [Abstract][Full Text] [Related]
12. Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I.
Zerboni L; Reichelt M; Jones CD; Zehnder JL; Ito H; Arvin AM
Proc Natl Acad Sci U S A; 2007 Aug; 104(35):14086-91. PubMed ID: 17709745
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region.
Jones JO; Sommer M; Stamatis S; Arvin AM
J Virol; 2006 Mar; 80(6):3116-21. PubMed ID: 16501125
[TBL] [Abstract][Full Text] [Related]
14. Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication.
Berarducci B; Sommer M; Zerboni L; Rajamani J; Arvin AM
J Virol; 2007 Oct; 81(19):10258-67. PubMed ID: 17634217
[TBL] [Abstract][Full Text] [Related]
15. Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.
Berarducci B; Rajamani J; Zerboni L; Che X; Sommer M; Arvin AM
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):282-7. PubMed ID: 19966293
[TBL] [Abstract][Full Text] [Related]
16. Varicella-Zoster virus IE63, a major viral latency protein, is required to inhibit the alpha interferon-induced antiviral response.
Ambagala AP; Cohen JI
J Virol; 2007 Aug; 81(15):7844-51. PubMed ID: 17507475
[TBL] [Abstract][Full Text] [Related]
17. Absence of varicella-zoster virus (VZV) glycoprotein V does not alter growth of VZV in vitro or sensitivity to heparin.
Cohen JI; Seidel KE
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3087-93. PubMed ID: 7964618
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids.
Mallory S; Sommer M; Arvin AM
J Infect Dis; 1998 Nov; 178 Suppl 1():S22-6. PubMed ID: 9852968
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection.
Oliver SL; Yang E; Arvin AM
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795423
[TBL] [Abstract][Full Text] [Related]
20. Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts.
Sadaoka T; Yoshii H; Imazawa T; Yamanishi K; Mori Y
J Virol; 2007 Nov; 81(22):12654-65. PubMed ID: 17855513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
